Records containing: Refractory Malignant Ascites
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-04-12A Phase 1b Dose-escalation and Cohort-expansion Study of the Safety/Tolerability, and Efficacy of Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites (OPTIONS-02)
-
CLINICAL_TRIALS study record update · 2023-01-31A Phase II Study of Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites
-
CLINICAL_TRIALS study record update · 2022-01-12Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology
-
CLINICAL_TRIALS study record update · 2018-08-14Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites
-
CLINICAL_TRIALS study record update · 2013-05-21Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites.
- Organize your saved records without ads with Plus.